Heartseed

  • NEWS
  • PIPELINE
  • TECHNOLOGY
  • ABOUT US
    • CEO Message
    • Purpose
    • Company Profile
    • Management
  • Mission & Values
  • IR
    • IR News
    • Management
    • IR Library
    • Stock Information
    • Other Contents
  • CONTACT
  • JP/EN
  1. HOME
  2. NEWS
  3. 2023

2023

2023216

Congress Takehiko Kaneko, CMO and Head of R&D at Heartseed, is speaking at this year's Next Generation Cardiovascular Drug Development in April 25-27.

2023216

Congress Takehiko Kaneko, CMO and Head of R&D at Heartseed, is speaking at this year's iPSC Manufacturing Summit in May 2-4.

2023210

PR Heartseed and Novo Nordisk announce first patient dosed in clinical study with HS-001 - a cell therapy designed to restore heart function in people with advanced heart failure

1 2

COMPANY OVERVIEW

To transform treatment of severe heart failure by delivering cardiac regenerative medicine, Heartseed Inc. was founded in 2015. It has also been developing technologies to expand the access of RM.

Company name
Heartseed Inc.
Head Office
Seavans South Building 5F, 1-2-3 Shibaura, Minato-ku, Tokyo 105-0023, JAPAN
Contact
contact@heartseed.jp

MORE VIEW

MENU

  • Home
  • News
  • PIPELINE
  • TECHNOLOGY
  • About us
  • Mission & Values
  • IR
  • Contacts

language

  • English
  • Japanese

GO TO TOP

Copyright © All Rights Reserved HEARTSEED HEARTSEED